Notably, RCE plus Oxa caused on average 20.5-and 1.8-fold increases in the levels of released IL-2 and GrB, respectively, suggesting that hPD-1 tumor-infiltrating CD8+ T cells activated by combination therapy secrete IL-2 and GrB. This evidence concerns the gene CD8A and neoplasm.